International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS | IASSS
Integrated Societies: IATSIC | IASMEN | BSI | ISDS | IASSS
| Time | Session |
|---|---|
|
10:30
10:37
|
INTEGRATING PERSONAL, HEREDITARY, AND POLYGENIC PROFILES VIA DEEP LEARNING-BASED RISK ESTIMATION FOR PRECLINICAL BREAST CANCER DIAGNOSIS
3103-01
Room: Monterrey A-C (Floor1)
|
|
10:37
10:44
|
“THE TRIPLE TROUBLE” -VIRAL MARKER POSITIVITY, TUMOR AGGRESSIVENESS, AND OPPORTUNISTIC INFECTIONS IN BREAST CANCER
3103-02
Room: Monterrey A-C (Floor1)
|
|
10:44
10:51
|
THE ASSOCIATION OF BODY MASS INDEX (BMI) AND HEIGHT WITH ONCOTYPE DX SCORES IN WOMEN WITH HORMONE RECEPTOR POSITIVE HER 2 NEGATIVE BREAST CANCER IN THE NYC METROPOLITAN AREA
3103-03
Room: Monterrey A-C (Floor1)
|
|
10:51
10:58
|
THE IMPACT OF METABOLIC SYNDROME ON THE DIAGNOSIS OF SECOND PRIMARY TUMORS IN WOMEN TREATED FOR BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
3103-04
Room: Monterrey A-C (Floor1)
|
|
10:58
11:05
|
INFLUENCE OF GERIATRIC ASSESSMENT ON TREATMENT DECISIONS IN ELDERLY BREAST CANCER PATIENTS
3103-05
Room: Monterrey A-C (Floor1)
|
|
11:19
11:26
|
MINIMALLY INVASIVE RADIOFREQUENCY ABLATION (RFA) THERAPY IN PATIENTS WITH EARLY-STAGE BREAST CANCER
3103-08
Room: Monterrey A-C (Floor1)
|
|
11:26
11:33
|
CLINICAL CHARACTERISTICS OF HER2-LOW BREAST CANCER COMPARED TO HER2-NEGATIVE BREAST CANCER
3103-09
Room: Monterrey A-C (Floor1)
|
|
11:40
11:47
|
ENDOSCOPIC BREAST SURGERY FOR PERSONALIZATION OF BREAST CANCER TREATMENT
3103-11
Room: Monterrey A-C (Floor1)
|
|
11:47
11:54
|
RE-SENTINEL NODE BIOPSY IN PATIENTS WITH IPSILATERAL BREAST CANCER RECURRENCE AFTER BREAST CONSERVING SURGERY
3103-12
Room: Monterrey A-C (Floor1)
|